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Figure 1. (A) Outerbridge Grade IV osteochondral defect of medial femoral
condyle. (B) 1511 mm Chondroﬁx Osteochonfral Allograft immediately
after implantation
Figure 3. Arthroscopic examination of intact Chondroﬁx Osteochondral
Allograft 25 months after implantation revealing smooth borders without
step-off (A,B).
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DIFFERENCES IN CARTILAGE REPAIR OF LOADING AND UNLOADING
ENVIRONMENT IN THE RAT KNEE
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Purpose: We investigated histopathologically and immunohis-
tochemically effects of loading on cartilage repair in rat full-thickness
articular cartilage defects.
Methods: A total of 40 male 9-week-old Wistar rats were used. Full-
thickness articular cartilage defects were created over the capsule at the
loading portion in the medial condyle of the femur. Twenty rats were
randomly allocated into each of a loading group and non-loading group.
Twenty rats from these two groups were later randomly allocated to
each of 2 groups for evaluation at 1 and 2 weeks after surgery. At the
end of each period, the tissue of the defects were examined histo-
pathologically and immunohistochemically.
Results: In both groups at 1 and 2 weeks, the defects were ﬁlled with
mixture of granulation tissue and some remnants of hyaline cartilage.
The repair tissue were not stained with Toluidine blue in the both
groups. However, the adjacent articular cartilage to repair tissue in a
loading group were more strongly and thickly stained with Toluidine
blue than that in non-loading group. Strong staining of type I collagen
was observed in repair tissue of the both groups. The area stained with
type I collagen in non-loading group was smaller than that in loading
groups. However, apparent staining of type II collagenwas not detected
in any repair tissue of the both groups.
Conclusions: Non-weight bearing in the early phase of an articular
cartilage defect may be accompanied by a good tissue repair, althogh
non-weight bearing may decrease the function of adjacent normal
cartilage.Fig. 1. Histopathological and immunohistochemical staining of the repair
tissue.Sagittal sections of full-thickness articular cartilage defects in the
loading group (A-D, I-L) and non-loading group (E-H, M-P) at 1week (A-
D, E-H) and 2 weeks (I-L, M-P). The sections were stained with hema-
toxylin and eosin (A, E, I, M), Toluidine Blue (B, F, J, N) and immuno-
histochemical staining for type I collagen (C, G, K, O) and type II collagen
(D, H, L, P). Scale bar ¼ 500 mm.Cell Signaling
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DKK1, FRZB, GREM1 PREVENT IL1B INDUCED ARTICULAR CARTILAGE
DEGRADATION
L. Zhong, M. Karperien, J.N. Post. MIRA Inst. for BioMed. technology and
technical medicine, Enschede, Netherlands
Purpose: Osteoarthritis (OA) is a multifactorial disease characterized by
progressive degradation of articular cartilage leading to loss of joint
function. It affects several million people in the world. Currently there is
no cure for OA. In a subset of patients OA is associated with hyper-
trophic differentiation of articular chondrocytes. This process normally
occurs in the growth plate. Healthy articular cartilage is protected
against hypertrophy. Our group identiﬁed DKK1, FRZB (WNT antago-
nists) and GREM1 (BMP antagonist) as the natural brakes on hyper-
trophic differentiation and regulation of the maintenance of the
articular phenotype. Moreover, we previously demonstrated that
decreased production of DKK1, FRZB, GREM1 in human chondrocytes
has been associatedwith cartilage hypertrophy in OA. In this project, we
hypothesize that DKK1, FRZB, GREM1 are the gatekeepers for the
maintenance of homeostasis in articular cartilage. To prove this, we
investigated whether knockdown of DKK1, FRZB and GREM1 is sufﬁ-
cient to cause hypertrophic differentiation in healthy articular chon-
drocytes. Furthermore, we investigated the inﬂuence of catabolic
factors such as interleukin-1b (IL-1b) on the gene transcription levels of
DKK1, FRZB, GREM1. We found that the presence of DKK1, FRZB and
GREM1 is sufﬁcient to inhibit the catabolic effects of IL-1b.
Methods: Human primary chondrocytes (hCh) were isolated from
cartilage as described previously by our group. We isolated a neutral-
izing VhH antibody against DKK1 from a llama VhH library and used this
to block DKK1 activity in human primary chondrocytes cultured in
monolayer. The chondrocytes were cultured in chondrocyte pro-
liferation medium containing 5 mg/ml neutralizing antibody for 1 week.
Normal IgG served as a negative control. The neutralizing function of
the antibody was tested before use. Isolated chondrocytes were
exposed to 10ng/ml of recombinant human IL-1b, and 200ng/ml of each
of DKK1, FRZB, GREM1 (all recombinant proteins are from R&D sys-
tems). Cells received no medium refreshment after stimulation and
were cultured up to 48 hours.
Results: In the presence of recombinant DKK1 protein the mRNA
expressionof theWNT targetgeneAXIN2wasdownregulated. Inpresence
of both DKK1 and the DKK1 neutralizing antibody, AXIN2 mRNA was
upregulated suggesting that the WNT signal pathway activity was (re)
activated.MMP1, 3and13aswell asRUNX2wereupregulated in cellswith
DKK1 knockdown. The expression of Col10 could not be detected. This
Figure 1. A complex network of many signal transduction pathways
determines the development of either transient or permanent cartilage.
ECHO consists of 123 nodes with 354 interactions. We can perform in
silico experiments using the complete network, or investigate detailed
processes in smaller areas of the network.
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hypertrophic differentiation of articular chondrocytes.
After addition of 10 ng/ml IL-1b DKK1 and FRZB mRNA levels were
decreased while expression of GREM1 mRNA was increased (ﬁgure 1).
IL-1b is a potent activator of MMP expression in human chondrocytes
and has been implicated in cartilage degradation in OA. As expected, IL-
1b potently induced expression of MMP1, MMP3, and MMP13 at the
mRNA level. Co-stimulation with IL-1b and DKK1 or GREM1 further
increased IL-1b-induced MMP expression. Especially MMP3 was
increased signiﬁcantly. Surprisingly, the addition of DKK1, FRZB and
GREM1 simultaneously in the presence of IL-1b reduced MMP gene
expression to undetectable levels (ﬁgure 2). This suggests that the
combination of three antagonists can effectively counteract IL-1b
induced catabolic activity in human chondrocytes.
Conclusions: Hypertrophic differentiation may play a role in early and
late stage OA. Inhibition of hypertrophy by DKK1, FRZB and GREM1
might be a therapeutic target to slow down further OA progression.
DKK1 plays a crucial part in preventing chondrocytes from hypertrophy.
Furthermore, we found that the expression of DKK1, FRZB, GREM1 in
human primary chondrocytes was affected by the osteoarthritis asso-
ciated factor IL-1b. We also provided evidence that, even in the presence
of IL-1b, the combination of three antagonists completely inhibited the
expression of genes associated with chondrocyte hypertrophy and OA.
Figure 1. Effects of IL1b on the mRNA expression of DKK1, FRZB, GREM1.
Human chondrocytes received a single dose of 10ng/ml IL-1b. Antagonists
mRNA expression was measured by qRT-PCR. * P < 0.05. Student T-test.
Figure 2. Chondrocytes in monolayer cultures were exposed to 10ng/ml of
recombinant human IL-1b, and 200ng/ml each of DKK1, FRZB, GREM1 for
48 hours. MMP expression was measured by qRT-PCR.
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AN ECHO IN BIOLOGY: VALIDATING THE EXECUTABLE
CHONDROCYTE
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J.N. Post y. yMIRA Inst. for BioMed. technology and technical medicine,
Enschede, Netherlands; zCTIT Inst. - Univ. of Twente, Enschede,
NetherlandsPurpose: Computational modeling of biological networks permits
comprehensive analysis of cells and tissues to deﬁne molecular phe-
notypes and novel hypotheses. We recently presented ANIMO (Analysis
of Networks with Interactive Modeling), an intuitive software tool for
modeling molecular networks for use by biologists. We used ANIMO to
generate a computational model of articular cartilage, ECHO.
Over 1.5 million people in the Netherlands suffer from osteoarthritis
(OA) in one or more joints. OA is a painful, disabling disease and cur-
rently cannot be cured. In a subset of OA patients, joint cartilage is
replaced by bone via endochondral ossiﬁcation. This is a natural process
in growing long bones, where transient growth plate cartilage is
replaced by bone. In contrast, healthy joint cartilage is permanent as it is
protected against bone formation. Stable joint cartilage is under control
of master transcription factor SOX9, whereas bone formation is con-
trolled by RUNX2. The processes that regulate the switch between a
SOX9þ state and a RUNXþ state are poorly understood, which greatly
hampers the development of successful therapies.
Methods: Based on a large-scale literature study and our own experi-
ments, we recently developed ECHO (Executable Chondrocyte), a com-
putational model of the key processes that regulate expression and
activity of SOX9 and RUNX2. Simulations in ECHO were performed to
investigate the robustness of the chondrocyte network.
To validate ECHO predictions, we used FRAP to measure mobility of SOX9
andRUNX2,whichwehave shown to be a faithful readout of their activity.
Primary chondrocytes of 2 OA donors were tested at passage 2 after
isolation. In these donors we observed little interdonor variation in
SOX9 mobility. Using lipofectamine LTX we obtained 40-70% trans-
fection efﬁciencies in primary human chondrocytes even at low
passages.
Results: In its unperturbed form, ECHO displays two stable states in
which activities of SOX9 and RUNX2 are mutually exclusive. We tested
the hypothesis that addition of WNT (performed with a few mouse
clicks) will change permanent into transient cartilage by inducing
hypertrophy. Indeed, when we add WNT, a known regulator of bone
formation, the permanent or SOX9þ state changes to a transient or
RUNX2þ state. However, it is known that healthy articular cartilage is
resistant to hypertrophic differentiation. Our group has previously
found that this was probably due to the secretion of DKK1, FRZB and
GREM1. We therefore added nodes to ECHO representing DKK1, FRZB
and GREM1 (ﬁgure 1). GREM1 and DKK1 are able to stabilize the per-
manent cartilage or SOX9þ state even after addition of WNT to ECHO.
We observed that in our model activation ofWNT leads to a switch from
a SOX9þ state to a RUNX2þ state. To prove that WNT/b-catenin sig-
naling can directly regulate SOX9 function, we investigated the
response of SOX9 mobility to WNT3A in live primary chondrocytes.
Addition of WNT3A to human chondrocytes transfected with SOX9-GFP
resulted in a signiﬁcant decrease of the immobile SOX9 fraction from
53% to 34% within 15 minutes after addition. A direct correlation
between the elevated levels of b-catenin after WNT addition and the
activity of SOX9 indicates that b-catenin can directly change the
mobility by complex formation with SOX9.
Conclusions: Using ECHO we predicted the stimuli that prevents
hypertrophic differentiation differentiation of articular cartilage, and
tested this experimentally with FRAP using SOX9 and RUNX2 mobility
as a read-out.
